DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Fosnetupitant chloride hydrochloride; palonosetron hydrochlorideis the generic ingredient in one branded drug marketed by Helsinn Hlthcare and is included in one NDA. There are nine patents protecting this compound. Additional information is available in the individual branded drug profile pages.
Fosnetupitant chloride hydrochloride; palonosetron hydrochloride has one hundred and sixty-three patent family members in forty-nine countries.
There is one drug master file entry for fosnetupitant chloride hydrochloride; palonosetron hydrochloride. One supplier is listed for this compound.
Summary for fosnetupitant chloride hydrochloride; palonosetron hydrochloride
|Drug Master File Entries:||1|
|Suppliers / Packagers:||1|
|DailyMed Link:||fosnetupitant chloride hydrochloride; palonosetron hydrochloride at DailyMed|
Pharmacology for fosnetupitant chloride hydrochloride; palonosetron hydrochloride
|Drug Class||Serotonin-3 Receptor Antagonist |
|Mechanism of Action||Serotonin 3 Receptor Antagonists |
|Patent Number||Supplementary Protection Certificate||SPC Country||SPC Expiration||SPC Description|
|2785706||2020C/516||Belgium||Start Trial||PRODUCT NAME: AKYNZEO - FOSNETUPITANT/PALONOSETRON; AUTHORISATION NUMBER AND DATE: EU/1/15/1001 20200318|
|2785706||122020000046||Germany||Start Trial||PRODUCT NAME: FOSNETUPITANT MIT PALONOSETRON; REGISTRATION NO/DATE: C(2020)1804(FINAL) 20200316|
|2785706||2090015-5||Sweden||Start Trial||PRODUCT NAME: FOSNETUPITANT; REG. NO/DATE: EU/1/15/1001 20200317|
|2785706||132020000000094||Italy||Start Trial||PRODUCT NAME: FOSNETUPITANT O UN SUO SALE FARMACEUTICAMENTE ACCETTABILE, IN PARTICOLARE IL SUO SALE CLORURO CLORIDRATO(AKYNZEO); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/15/1001/001-002, 20200316|
|2785706||CA 2020 00028||Denmark||Start Trial||PRODUCT NAME: FOSNETUPITANT OG FARMACEUTISK ACCEPTABLE SALTE ELLER SOLVATER HERAF, SAERLLIGT FOSNETUPITANT KLORID HYDROKLORID; REG. NO/DATE: EU/1/15/1001 20200318|
|>Patent Number||>Supplementary Protection Certificate||>SPC Country||>SPC Expiration||>SPC Description|
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.